Malignant hyperpyrexia is recognised as a potentially fatal disease under general anaesthesia I. For this reason many would advocate an exhaustive testing of any family suspected of harbouring this dominant autosomal gene'.
Because the investigations rely on assessing skeletal muscle contraction with provocative agents such as caffeine, halothane and potassium chloride 3 , the muscle must be viable and able to contract. Therefore in Australia and overseas, all testing laboratories arrange for the biopsy to be taken at the nearest hospital and in vitro testing to be performed immediately on the fresh muscle. Our search of the literature failed to find any guidance on the maximum duration of storage of the specimen before the testing would be impossible and/or the results would be invalid.
Because this patient was not able to travel to a laboratory, we therefore considered remote testing.
This case report highlights the logistical factors, the steps taken in the biopsy and the delivery of the muscle specimen to ensure that it was viable for the tests for malignant hyperpyrexia.
We believe this is the first time that a patient has not been close to a laboratory when the testing was done.
CASE REPORT
The patient was admitted to a local hospital after he had been found unconscious at home. Urinary screening subsequently proved positive for benzodiazepines and cannabinoids.
Upon admission he was intubated using suxamethonium and transferred to the Intensive Care Unit (ICU) for ventilatory support and management of an aspiration pneumonia. His temperature on admission was 35 QC but he was normothermic 15 hours later.
A serum creatine kinase (CK) level was elevated at 2,262 U (normal level for males is 60-270 U). This was attributed to pressure-induced rhabdomyolysis. The temperature readings and CK values for the first eleven days are shown in Figure 1 . It can be seen that the peaks in temperature appear to be related to the administration of suxamethonium in two instances and isoflurane in the later incident.
The following day he was extubated but again deteriorated and was re-intubated using suxamethonium. Unfortunately a right tension pneumothorax occurred and was drained. The patient was continued on intermittent positive pressure ventilation (IPPV).
Over the next five days the patient was relatively stable on IPPV but he continued to have febrile peaks (38.0 to 39.0 QC). Initially the P a C0 2 was elevated to about 60 mmHg but settled to 46-48 mmHg with an increase in minute volume to 14 litres. However, he continued to have a persistently low Pa0 2 (40-80 mmHg) on added oxygen. During this period serum potassium levels remained within the normal range but a retrospective CK level was found to be markedly elevated at 17,800 U.
On the seventh day, the cause of the continuing high temperature, a right-sided empyema, was found and drained. The anaesthetic given was fentanyl, with increased midazolam and vecuronium infusions, and isoflurane 0.5-1.0%. During the operation, the PaC0 2 gradually rose from 42 mmHg to 52 mmHg and the Sp02 fell from 99070 to 96%. The blood pressure rose from 120 to 145 mmHg systolic. The pulse rate was not recorded, nor was any change noted in the patient's colour, his temperature, nor the temperature of the soda lime canister.
The patient returned to the ICV and over the next hours his temperature rose to 41.5 QC. He was given 1.0 g paracetamol PR with no effect. When his temperature peaked at 42.2 QC, a diagnosis of malignant hyperpyrexia (M H) was considered. Dantrolene 80 mg IV and indomethacin 100 mg PR were given, and active cooling was begun. His temperature gradually settled to 39.8 QC over several hours but rose again and was treated with further dantrolene (120 mg IV). There were increases also in the serum potassium to 6.3 mmolll and urea to 39.9 mmolll. The CK level was grossly elevated at 145,642 U.
On the eighth day he was transferred from the local hospital to The Queen Elizabeth Hospital (TQEH) with suspected malignant hyperpyrexia.
Vpon transfer, a urine sample was sent for myoglobin levels, but unfortunately this was lost and thereafter his renal output rapidly diminished.
Later that day, there was an increase in temperature to 40.1 QC. Another 120 mg dantrolene was given and the temperature rapidly decreased to 38.7 QC and then settled to 37.5 QC over the next six hours.
On the ninth day the highest CK level of 164,500 V was recorded. Temperature remained 37.5-37.8 QC until late afternoon when it again rose to 38.9 QC and was again treated with a further 120 mg dantrolene IV. Four hours later the temperture had fallen to 37.3 QC.
Over the following days a low grade fever of 37.4-38.3 QC persisted but there were no recurrences of febrile peaks. However, at this stage he required continuous arteriovenous haemodialysis (CAVHD). The ABGs and serum biochemistry results showed a return to normal values except for raised urea and creatinine levels. The CK level on the 11th day had fallen to 79,200 U.
A tracheostomy was subsequently performed using increased sedation and muscle relaxation with the addition of intravenous analgesia. The perioperative course was uneventful. Subsequent checking of the patient's medical history revealed that he had had several general anaesthetics with volatile agents and two including suxamethonium, all without major problems being noted. Some postoperative rise in temperature occurred on one occasion, presumably caused by sepsis, but the patient remained afebrile after another general anaesthetic which included suxamethonium. In addition, the family history showed no evidence of malignant hyperpyrexia.
The patient remained unconscious on IPPV and it became evident that he had a flaccid peripheral paralysis. Electro-myographic (EMG) studies demonstrated a mixed and neuropathic picture. This was thought to be due to the MH-induced gross rhabdomyolysis and a neuropathy resulting from the severe acute illness.
There remained the problem of a definitive diagnosis in this patient and its subsequent bearing on the other members of his family, in particular his two daughters (aged 11 and 13 years). The circumstantial evidence strongly suggested malignant hyperpyrexia, and therefore specific testing of a skeletal muscle biopsy was indicated. However, there were two major problems in this particular situation.
Firstly, the patient remained ventilator-dependent in a hospital in Adelaide (South Australia). The nearest laboratories where the specific muscle testing for MH is performed are in Canberra (Australian Capital Territory), approximately 1600 km away, and Melbourne (Victoria), approximately 800 km distant. Transport of the patient to either site would have been hazardous, expensive and difficult logistically. The alternative of transporting the fresh muscle biopsy had not previously been attempted as far as we could ascertain.
Secondly, this patient had a dense peripheral flaccid paralysis with gross wasting, and the quality of the skeletal muscle that was available was doubtful. It was therefore decided to wait and see if he would survive, and achieve a return of muscle function. The family were informed as to the suspected nature of his condition and of the above decision and its rationale. They were advised also that the family members must be considered at risk until definitive muscle testing had been performed.
Over the following weeks the patient showed a gradual return of consciousness. Five months after his initial admission to hospital he was quadriplegic with a dense flaccid paralysis and marked peripheral muscle wasting. However, he was conscious and able to communicate basic feelings by facial ex-pression. He had return of cranial motor function, with diaphragmatic breathing and the ability to shoulder shrug. He breathed spontaneously through his tracheostomy tube for most of the day but required ventilatory support at night. It was felt that little, if any, further improvements in peripheral muscle function would occur in the near future.
It was obvious that this patient would never be able to travel interstate for the required muscle testing, and so the decision was made to make arrangements for the muscle biopsy to be taken and delivered to the laboratory at the Royal Melbourne Hospital (RMH).
PREPARATION FOR MUSCLE BIOPSY
All arrangements by staff at TQEH were made in close liaison with the staff of the MH laboratory at the RMH. The special problems that were to be faced in this situation fell into three main areas: 1. Identification of skeletal muscle suitable for biopsy 2. Preservation of the muscle biopsy specimen 3. Co-ordination and timing of services for rapid transport of specimen.
Identification of muscle specimen
The patient still had a dense flaccid paralysis of mainly a lower motor neurone type. However, it was felt that if muscle contraction could be demonstrated by direct or indirect electrical stimulation in the quadriceps group (which is the muscle normally used) then this would be the most appropriate muscle from which to take the biopsy. Although he had active contraction of his upper trapezei, these muscles were of marked importance in his daily activities and it was thought safer not to interfere with their function.
Muscle testing was performed one week before the planned biopsy. Peripheral nerve stimulation of both femoral nerves with both a tetanic stimulus of 50 Hz and a "train-of-four" failed to demonstrate any activity at all in the quadriceps. However, direct muscle stimulation with a square wave pulse of 2 msec duration via needle electrodes produced a weak but visible response. The area of contracting muscle was marked in preparation for the taking of the specimen. At operation, a specimen approximately 5 x 1.0 x 0.5 cm was removed from the lateral thigh. The longitudinal axis was aligned with the direction of the muscle fibre and removal was by sharp cutting with no stretching or bruising and without diathermy to try to ensure good viability.
Preservation of the muscle biopsy specimen
From the experience of the MH laboratory at RMH, it was felt that a specimen would remain viable in a test bath for two hours at 37 QC. The test procedures normally occupied one hour which left at least one further hour available. The rate of most chemical reactions are temperature-dependent. This is usually measured as the change in reaction rate for every 10 centigrade degree change and is termed the QIO. For biological reactions the rate change is about twofold. Therefore, if the temperature was reduced to 4 QC, the viability of the muscle should be extended with metabolism reduced to about 1OOJo of normal (1/233) and the viability time extended for many hours. However, as this was speculation, it was essential to keep the interval between taking of the specimen and the testing as short as possible.
One litre of the bath solution (see Appendix A) was prepared two days before the scheduled biopsy and cooled in ice slurry. It was then gassed with Carbogen (nominally 95OJo O 2 and 5OJo CO 2 ). It was kept at about 0 QC and allowed to stand overnight. A further gassing for about three hours was repeated the next day while the bottle was kept cold. It was then tightly capped and kept overnight in ice slurry in a closed polystyrene lidded box.
After the muscle biopsy had been taken, it was placed in a large specimen container and covered immediately with about 200 ml of the ice cold solution and then tightly capped. This container was placed in the box with the ice slurry.
Co-ordination and timing of services for rapid transport
The timing of this transport differs from that of donor organs, which are usually urgent procedures done by a dedicated aircraft as soon as a donor becomes available. The taking of this biopsy, however, was arranged to fit the speediest commercial transport profile. The situation was discussed with Qantas Australian Airlines and their full co-operation was given at all stages. The mid-morning flight (after the early morning interstate businessmen's rush) departing 10:00 hours was booked (although departure was subsequently delayed).
(a) Surgical biopsy
At 08:00 the patient was transferred from the ICU to the theatre suite. Under regional block using 0.5OJo plain bupivacaine to the left femoral nerve and lateral cutaneous nerve of the thigh, surgical exposure of the left anterior quadriceps was complete by 08:50 hours. At this stage the Qantas traffic office was telephoned to check the flight information. As the departure of the scheduled flight had been delayed by the late arrival of the inward flight, the taking of the biopsy specimen was deferred for a further 15 minutes until 09:18 hours.
(b) TQEH to Adelaide Airport
With a mid-morning flight it was anticipated that road traffic delay would be minimal during the 5 km journey from the TQEH to the airport. The estimated travelling time was 15 minutes, but the actual time taken was only 11 minutes.
(c) Flight to Melbourne A seat adjacent to the forward exit had been allocated to facilitate early disembarkation. The flight time was 55 minutes and the plane arrived at 11:45 hours Melbourne time (11:15 hours Adelaide time). The specimen in the polystyrene box was carried as hand luggage (WJR).
(d) Melbourne Airport to RMH
The late morning arrival also avoided traffic congestion on the freeway from the airport into Melbourne (20 km away). The estimated travelling time for the journey to the RMH was 60 minutes. Actual time by taxi was 32 minutes.
(e) RMH laboratory On arrival, the muscle specimen was removed from its cold environment, dissected into strips at room temperature for testing and then placed into an organ bath at 37°C in fresh Kreb's solution with actively bubbling Carbogen. The muscle testing was commenced 32 minutes later, 182 minutes after removal from the patient. There was a good twitch response to 2 Hz stimulation with 1 ms square wave with 1.0 g tension. Final testing, with halothane, was completed four hours after the specimen was removed.
RESULTS
The stimulated caffeine responses of the muscle specimen are shown in Figure 2 . It can be seen that there is a normal response with no increase in baseline until exposure to 8 mmolll caffeine. The usual response with malignant hyperpyrexia is contraction from the baseline with caffeine concentrations below 1 mmolll. Similarly there was a normal response (no contraction) to halothane. The viability and responsiveness of the muscle were demonstrated by a strong normal contraction response to 80 mmolll KCI.
These responses indicated that this man did not have malignant hyperpyrexia. The cause of his exteme elevations of creatine kinase are not obvious. Possibly the denervation caused by his amitriptyline and the Anaesthesia and Intensive Care, Vol. 22, No. 4, August, 1994 muscle wasting of his prolonged illness allowed further breakdown as a response to suxamethonium and general anaesthesia. 
DISCUSSION
We believe that this is the first time a patient has had' a muscle biopsy test for malignant hyperpyrexia over 800 km from the laboratory. Although this method is unlikely to be required often, it opens a possibility for remote areas that have a transport connection less than a few hours to an MH laboratory. As the need for muscle testing is infrequent, if the viability of muscle after biopsy can be extended to seven hours, it opens up the possibility of two testing centres being adequate for the whole of Australia, For example, a four-hour flying radius from Adelaide and a similar radius from Brisbane covers all the major population centres in Australia. Against this must be set the cost of any delay in getting the muscle specimen to the test laboratory which could render the whole exercise futile. Also, a further biopsy cannot be taken if the specimen does not show a good contractile response. The remote technique should not be considered an optional alternative to the normal practice of having the patient attend the testing laboratory. However, it may be useful when the patient is unable to travel.
The normal response to caffeine and halothane is unlikely to be an artefact. There is no reason in this to expect that the cool storage in Kreb's solution modified the muscle behaviour to create a false negative response. The viability of the muscle was clearly demonstrated by the twitch responses, the caffeine response and the response to KC!.
The final diagnosis of this patient remains uncertain. It is possible that this is an extreme example of the malignant neuroleptic syndrome from the unknown drugs which he took. Certainly, the malignant neuroleptic syndrome is characterised by fever, muscle rigidity and elevated creatine kinase 4 -6
• This is consistent with our patient's presentation. Although the management of this patient has not been altered by the exclusion of malignant hyperpyrexia, the result is reassuring for his two children.
APPENDIX A Muscle Nutrient Solution (Modified Kreb's) Initial solution is made up containing
NaCl, sodium chloride KCI, potassium chloride MgS0 4 .7H 2 0, magnesium sulphate heptahydrate KH 2 P0 4 , potassium dihydrogen 13.804 g 0.506 g 0.394 g orthophosphate 0.326 g NaHC0 3 , sodium bicarbonate 4.200 g Glucose 3.998 g These reagents are added together and dissolved in about 1800 ml of distilled water. A second solution is made up containing CaCI 2 .2H 2 0, calcium chloride dihydrate, 0.735 g, dissolved in 100 ml of distilled water.
These solutions may be kept apart indefinitely. Before use, the two solutions are mixed thoroughly and made up to a final volume of 2.0 litres.
The final solution should be chilled to 4 QC and gassed with Carbogen (95070 °2, 5070 CO 2 ) 1 litre/min for one hour in a covered conical flask using a fine bubbler. During the gassing, the flask should be immersed in ice slurry to ensure that there is saturation with the Carbogen. Before use the solution is stored at about 4 QC in a refrigerator or in ice slurry.
The muscle specimen is placed in a 100 ml container and then the container filled with the nutrient solution. During transport, the container should be kept cool, e.g. in a polystyrene "Esky" with cold bags.
